Where does Institute for Cancer Research rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Institute for Cancer Research ranks #5,846 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Institute for Cancer Research hold?

Institute for Cancer Research holds 58 US utility patents granted between 2015 and 2025, spanning 20 technology areas.

What is Institute for Cancer Research's Innovation Score?

Institute for Cancer Research has an Innovation Score of 43.1 out of 100 (top 29% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Institute for Cancer Research focus on?

Institute for Cancer Research's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 32 patents, ranking #706 of 7,163 assignees active in that subclass. Grants appear in 20 CPC subclasses total.

Is Institute for Cancer Research's patent grant rate increasing or decreasing?

Institute for Cancer Research's recent grant velocity is +26% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Institute for Cancer Research's patents?

Institute for Cancer Research's patents average 13.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Institute for Cancer Research patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Institute for Cancer Research

USPTO PatentsView assignee record - 58 granted patents across 20 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Institute ranks #5,846 of 49,997 tracked US assignees by granted-patent volume, with 58 patents across 20 technology areas.

#5,846
of 49,997 US assignees by volume: Top 29%
by Innovation Score (43.1/100): 13.3
avg claims per patent: +26%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5846 · US Corporation #5,846 · 58 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 58 grants
UPPER-Q #5,846/49,997
PHOTO-FINISH Genia
CPC-FOCUS A61K · 20 areas
INNOV-PAR 43.1/100
CLAIMS-RICH 13.3 claims/avg
TYPE-USCORP US Corporation
VEL-UP +26% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Genia Technologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Institute’s 43.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.1 pts (33%) Velocity 5.3 pts (12%) Breadth 15.8 pts (37%) Claim depth 8.0 pts (19%)

Qualcomm Incorporated · highest

85
Institute for… · this assignee

43
Smart ULC · near

43
Universite D'angers · near

43
Vocollect · near

43
Adama Makhteshim · near

43
3D Lighting… · lowest

7

What this shows Institute's Innovation Score is 43.1/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Institute?

Each dot is one of Institute’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Institute’s own 13.3 claims/patent is at or below the 14.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Institute vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Institute's grants concentrate

Institute for Cancer Research is a focused PatentsView assignee: 20 CPC subclasses with 55.2% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2017 (7 grants) versus a trough of 2 in 2018. By volume, Institute sits between Grass Valley Canada and Jiangsu Midea Cleaning Appliances Co., Ltd..

Institute's three-year grant acceleration

Institute for Cancer Research shows 15 grants in 2022–2024 against only 19 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Grass Valley Cana…

58
Genia

58
Gilbarco

58
Horizon Hobby

58
Institute of Chem…

58
Intellijoint Surg…

58
JD com American

58
Jiangsu Midea Cle…

58
Institute for Can… ◀

58

What this shows Institute holds 58 patents at rank #5,846, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Institute

By rank, the assignees closest to #5,846 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Institute's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Institute, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Institute ranks #706 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (43 here).

Vocollect, Inc. 43 Smart Technologies ULC 43 Universite D'angers 43 Adama Makhteshim Ltd. 43

Similar claim depth

Nearest assignees by average claims per patent (13.3 here).

Depuy Ireland Unlimited Company 13.3 avg Coloplast A/S 13.3 avg TDK—Micronas GmbH 13.3 avg Nien Made Enterprise Co., Ltd. 13.3 avg

Institute's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 29% higher than 71% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Institute for Cancer Research patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	8.6%
2016	4	6.9%
2017	7	12.1%
2018	2	3.4%
2019	5	8.6%
2020	7	12.1%
2021	7	12.1%
2022	5	8.6%
2023	4	6.9%
2024	6	10.3%
2025partial year	6	10.3%

Which technologies does Institute for Cancer Research patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 32

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 21

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 16

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 14

C07K - Peptides 13

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 11

A61B - DIAGNOSIS; SURGERY; Identification 9

C07D - Heterocyclic Compounds 9

C12Y - Enzymes 6

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 2

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 1

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 1

Top 15 of 20 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Institute for Cancer Research's patent record in context - here's where to go next.

Institute for Cancer Research's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 55.2% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #5,846 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Institute for Cancer Research against Grass Valley Canada, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.